# FDA Inspection 1192104 - Novartis Pharma Stein AG - December 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/5994d6f5-291c-4a32-87bf-4376f992a6bb
Source feed: FDA_Inspections

> FDA Inspection 1192104 for Novartis Pharma Stein AG on December 06, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192104
- Company Name: Novartis Pharma Stein AG
- Inspection Date: 2022-12-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1073408 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3f2284e9-7b71-4b40-a3f0-ac4686b89e80)
- [FDA Inspection 1015468 - 2017-05-09](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/41e9858b-8978-450a-9e2b-657833e31ff4)
- [FDA Inspection 947993 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6aecea73-0741-4c95-b1cf-6aedfc498659)
- [FDA Inspection 924507 - 2015-05-01](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/c4877126-7aef-4183-bd25-589a52fba74d)
- [FDA Inspection 875305 - 2014-03-25](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6894d4cd-3775-4701-bfbb-ced0311aec69)

Company: https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c